Keywords register: antipsychotics
Short report
50th anniversary issue 2008, suppl.2
25 years antipsychotics: back to the future?, 105 - 109
Review article
2019/10
Cariprazine for acute and maintenance treatment of schizophrenia, 702 - 709
New research
2017/6
Trends in antipsychotics use by Belgian children and adolescents between 2005 and 2014, 329 - 338
Review article
2016/9
Prolactin, antipsychotics and breast cancer: is there a connection?, 641 - 649
Case report
2016/4
Treatment-resistant psychosis due to interaction between ritonavir and olanzapine: case report and literature review, 309 - 313
New research
2015/3
Comparison between the regions of Belgium with regard to the amounts of antipsychotics prescribed during the period 2004-2012: a national survey, 161 - 170
Short report
2015/11
Amisulpride: a treatment option for psychotic disorders soon to be available in the Netherlands, 830 - 834
Short report
2015/2 themanummer Bewegingsstoornissen
The genetics of antipsychotic-related movement disorders, 114 - 119
Review article
2014/4
Treatment strategies for auditory verbal hallucinations, 247 - 256
Case report
2014/4
Post-injection delirium/sedation syndrome following injection of olanzapine pamoate: a new syndrome in emergency psychiatry, 273 - 276
Case report
2014/2
Mitigated presentation of the neuroleptic malignant syndrome, 114 - 117
Essay
2014/12
The new draft law on care and coercion. Concerning the use and the reduction of antipsychotics without a valid indication in people with intellectual disabilities, 807 - 815
Short report
2013/6
The need to monitor risk factors relating to patients on antipsychotics, 439 - 445
Case report
2013/5
An adolescent with autism and a somatic high-risk profile receiving treatment with antipsychotics refuses blood tests, 375 - 379
New research
2012/10
The relationship between antipsychotic-induced hyperprolactinemia and menstrual disorders in women with schizophrenia; a systematic review, 861 - 868
Review article
2011/2
Typical and atypical antipsychotics: Is there a difference in their influence on neurocognition?, 107 - 117
Review article
2011/2
Depot antipsychotics in the year 2011 , 95 - 105
Review article
2010/5
Antipsychotics and metabolic abnormalities in children and adolescents: a review of the literature and some recommendations, 311 - 320
Case report
2010/1
Antipsychotic agents and stimulants: a judicious combination? , 57 - 61
Case report
2009/1
Acquired stuttering in a psychotic patient , 53 - 57
Review article
2008/9
Prevention and treatment of somatic complications arising from the use of antipsychotics , 579 - 591
Review article
2008/10
Schizophrenia and antipsychotics associated with the metabolic syndrome. An overview, 645 - 654
Short report
2005/4
The effects of antipsychotics on patients with a dual diagnosis of schizophrenia and substance abuse. An opinion poll among experts , 253 - 257
Review article
2005/4
Effectiveness of antipsychotics in patients suffering from both schizophrenia and substance abuse: a literature review , 219 - 228
Case report
2003/5
Beta-blockers … an effective treatment of akathisia? A case study, 287 - 292